Jump to main content
Jump to site search


Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review

Author affiliations

Abstract

BODIPYs are photosensitizers activatable by light to generate highly reactive singlet oxygen (1O2) from molecular oxygen, leading to tissue damage in the photoirradiated region. Despite their extraordinary photophysical characteristics, they are not featured in clinical photodynamic therapy. This review discusses the recent advances in the design and/or modifications of BODIPYs since 2013, to improve their potential in photodynamic cancer therapy and related areas.

Graphical abstract: Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review

Back to tab navigation

Publication details

The article was received on 18 Mar 2018, accepted on 11 May 2018 and first published on 14 May 2018


Article type: Perspective
DOI: 10.1039/C8PP00113H
Citation: Photochem. Photobiol. Sci., 2018, Advance Article
  •   Request permissions

    Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review

    C. S. Kue, S. Y. Ng, S. H. Voon, A. Kamkaew, L. Y. Chung, L. V. Kiew and H. B. Lee, Photochem. Photobiol. Sci., 2018, Advance Article , DOI: 10.1039/C8PP00113H

Search articles by author

Spotlight

Advertisements